glp-1 gastroparesis treatment Gastroparesis: Hidden Dangers Beyond C Incidence of Gastroparesis with GLP-1

Many perimenopausal women are progesterone-deficient (due to anovulatory cycles) years before their estrogen significantly declines, and low progesterone is a primary driver of mood instability, sleep disruption, and anxiety in early perimenopause

Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases

However, it can also cause weight gain if your BMI is less than 30, as it did in another FDA-sponsored study that showed an increase in body mass index (BMI) among patients taking dapagliflozin over those who didn't take any diabetes medications at alla difference that could be due to water retention caused by treatment-emergent adverse effects such as hyponatremia (low sodium levels)

C

10.1007/s11033-019-04598-w Mol Biol Rep